BPC-157 Both Prevents and Heals Pancreatitis and Associated Gut Damage in Rats
BPC-157 showed both protective and healing effects in bile duct ligation-induced pancreatitis and the accompanying stomach and duodenal damage in rats.
Quick Facts
What This Study Found
BPC-157 demonstrated both prophylactic and therapeutic effects in bile duct ligation-induced pancreatitis, also improving concomitant gastric and duodenal lesions.
Key Numbers
How They Did This
Rat model of acute pancreatitis induced by bile duct ligation. BPC-157 was tested as either a pre-treatment (protective) or post-onset treatment (healing). Pancreatitis severity and gastroduodenal lesions were assessed.
Why This Research Matters
Acute pancreatitis has limited treatment options. A peptide that both prevents and heals pancreatic inflammation while also protecting the surrounding digestive tract addresses a significant unmet medical need.
The Bigger Picture
This study expanded BPC-157's documented benefits from the stomach and intestines to the pancreas, establishing it as a broad gastrointestinal protective and healing agent.
What This Study Doesn't Tell Us
Animal study using a surgical model of pancreatitis that may not perfectly represent human disease. Specific doses and quantitative results not detailed in abstract.
Questions This Raises
- ?Could BPC-157 be used prophylactically in patients at high risk for pancreatitis?
- ?What is BPC-157's mechanism of action in reducing pancreatic inflammation?
Trust & Context
- Key Stat:
- Both preventive and therapeutic BPC-157 reduced pancreatitis severity when given either before or after disease onset
- Evidence Grade:
- Moderate animal evidence with both prophylactic and therapeutic testing. Compelling results but limited to a surgical pancreatitis model.
- Study Age:
- Published in 1996, this is an early BPC-157 study expanding its known benefits to pancreatic protection.
- Original Title:
- Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.
- Published In:
- Digestive diseases and sciences, 41(7), 1518-26 (1996)
- Authors:
- Sikirić, P(10), Seiwerth, S(42), Grabarević, Z(9), Rucman, R, Petek, M, Jagić, V, Turković, B, Rotkvić, I, Mise, S, Zoricić, I, Jurina, L, Konjevoda, P, Hanzevacki, M, Ljubanović, D, Separović, J, Gjurasin, M, Bratulić, M, Artuković, B, Jelovac, N, Buljat, G
- Database ID:
- RPEP-00384
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is pancreatitis?
Pancreatitis is inflammation of the pancreas — the organ that produces digestive enzymes and insulin. Acute pancreatitis can be extremely painful and potentially life-threatening, with limited specific treatments available.
Why does pancreatitis cause stomach and duodenal damage?
When the pancreas becomes inflamed, digestive enzymes can leak and damage surrounding tissues. The bile duct ligation model used here also causes bile backup that damages the stomach and duodenum, mimicking what happens in severe human pancreatitis.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00384APA
Sikirić, P; Seiwerth, S; Grabarević, Z; Rucman, R; Petek, M; Jagić, V; Turković, B; Rotkvić, I; Mise, S; Zoricić, I; Jurina, L; Konjevoda, P; Hanzevacki, M; Ljubanović, D; Separović, J; Gjurasin, M; Bratulić, M; Artuković, B; Jelovac, N; Buljat, G. (1996). Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.. Digestive diseases and sciences, 41(7), 1518-26.
MLA
Sikirić, P, et al. "Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats.." Digestive diseases and sciences, 1996.
RethinkPeptides
RethinkPeptides Research Database. "Salutary and prophylactic effect of pentadecapeptide BPC 157..." RPEP-00384. Retrieved from https://rethinkpeptides.com/research/sikiric-1996-salutary-and-prophylactic-effect
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.